Fortrea Holdings Inc. (FTRE)
Sector: Services-Medical Laboratories
Industry: Biotechnology
Fortrea Holdings Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | 19.93 | 21.33 | 19.66 | 20.95 | 1,579,884 |
| Nov 2, 2026 | 21.41 | 21.56 | 19.75 | 20.02 | 1,752,186 |
| Oct 30, 2026 | 23.30 | 23.51 | 20.70 | 21.29 | 2,873,554 |
| Oct 29, 2026 | 23.63 | 23.79 | 22.41 | 23.14 | 4,953,134 |
| Oct 28, 2026 | 24.36 | 26.16 | 24.30 | 25.88 | 3,591,201 |
| Oct 27, 2026 | 23.73 | 24.52 | 23.50 | 24.43 | 1,973,479 |
| Oct 26, 2026 | 23.63 | 24.14 | 23.63 | 23.83 | 1,040,110 |
| Oct 23, 2026 | 23.92 | 24.05 | 23.42 | 23.63 | 1,000,270 |
| Oct 22, 2026 | 23.95 | 24.84 | 23.24 | 23.92 | 1,986,938 |
| Oct 21, 2026 | 22.45 | 24.37 | 22.30 | 24.06 | 2,476,748 |
| Oct 20, 2026 | 22.55 | 23.55 | 22.30 | 22.78 | 2,377,021 |
| Oct 19, 2026 | 22.49 | 23.04 | 22.38 | 22.42 | 1,652,350 |
| Oct 16, 2026 | 23.04 | 23.14 | 21.86 | 22.49 | 1,902,342 |
| Oct 15, 2026 | 21.93 | 23.07 | 21.63 | 22.75 | 2,910,404 |
| Oct 14, 2026 | 20.45 | 22.15 | 20.25 | 21.34 | 2,938,086 |
| Oct 13, 2026 | 21.11 | 21.21 | 20.60 | 20.92 | 764,312 |
| Oct 12, 2026 | 20.84 | 21.31 | 20.68 | 21.00 | 1,237,325 |
| Oct 9, 2026 | 20.37 | 21.00 | 20.16 | 20.84 | 931,309 |
| Oct 8, 2026 | 20.14 | 20.45 | 19.78 | 20.37 | 1,956,476 |
| Oct 7, 2026 | 20.38 | 21.11 | 20.24 | 20.56 | 2,245,344 |
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 Knoblauch Jason Fredrick | Chief Financial Officer | Grant/Award | 144.4K | -- | Sep 10, 2026 |
 Morais Mark A. | Chief Operating Officer | Sale | 3.1K | $53.1K | Sep 9, 2026 |
 Russell Carrie Elizabeth | Interim CAO | Sale | 246 | $4.1K | Sep 9, 2026 |
| Morais Mark A. | Chief Operating Officer | Option Exercise | 7.2K | -- | Sep 8, 2026 |
| Morais Mark A. | Chief Operating Officer | Option Exercise | 7.2K | -- | Sep 8, 2026 |
| Russell Carrie Elizabeth | Interim CAO | Option Exercise | 850 | -- | Sep 8, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
BlackRock, Inc. | 15.8M | 16.4% | 13F |
BlackRock, Inc. · also on 13F· may incl. warrants· filed Jul 2025 | 13.8M | 14.3% | 13G |
GOLDMAN SACHS GROUP INC | 8.4M | 8.7% | 13F |
Sessa Capital IM, L.P. | 4.6M | 4.8% | 13F |
VANGUARD CAPITAL MANAGEMENT LLC | 4.2M | 4.3% | 13F |
VANGUARD PORTFOLIO MANAGEMENT LLC | 3.8M | 4.0% | 13F |
STATE STREET CORP | 3.8M | 3.9% | 13F |
FMR LLC | 3.6M | 3.8% | 13F |
Corvex Management LP | 3.0M | 3.1% | 13F |
AQR CAPITAL MANAGEMENT LLC | 3.0M | 3.1% | 13F |
Insiders
- Knoblauch Jason FredrickChief Financial Officer
- Morais Mark A.Chief Operating Officer
- Russell Carrie ElizabethInterim CAO
- Thakral AnshulChief Executive Officer
- SANDERS MACHELLEDirector
- Smith David RossInterim CFO
- Ray AmritDirector
- Russell Erin LDirector
- Pesicka Edward ADirector
- NEUPERT PETER MDirector
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide.
It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process.
The company offers delivery models that include full service, functional service provider, and hybrid service structures.
It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services.
The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.
13F filers report 99.82M shares, more than the 96.50M outstanding, so no percentage is shown. 13F reports lag by a quarter and shares lent to short sellers can be counted twice.
US30d Avg
2.14M
60d Avg
1.88M
90d Avg
1.62M